Short answer
AdaptHealth Corp. (AHCO) filed its Q2 2026 10-Q quarterly report on Aug 4, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $600M (down 25.0% year over year) with net income of −$134M.
Q2 2026 key financials · XBRL
- Revenue
- $600M
- −25.0% YoY · −26.8% QoQ
- Net income
- −$134M
- −1012.7% YoY · −735.0% QoQ
- Operating margin
- -24.8%
- EPS (diluted)
- −$0.98
- −1080.0% YoY · −716.7% QoQ
Source: XBRL data from the AdaptHealth Corp. (AHCO) Q2 2026 10-Q on SEC EDGAR. USD.
AdaptHealth Corp. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $740.3M, up 12.7% YoY from $657.1M
- Operating margin (18.6%) vs 10.0% YoY, reflecting $144.2M goodwill impairment
- Best segment Sleep Health revenue $386.5M, up 15.5% YoY
- Worst segment Wellness at Home revenue $159.4M, up 4.9% YoY
- Diabetes Health sale for $235.0M cash expected to close Q1 2027; inflation and cybersecurity incident remain headwinds
Risk Factors
- New divestiture risk triggered by July 19, 2026 Diabetes Health sale agreement
- Hart-Scott-Rodino review could delay or prevent closing targeted for first quarter 2027
- Divestiture proceeds may fall short of expectations, limiting planned debt repayment and core-business investment
- Buyer indemnification and transition-services obligations may constrain post-closing cost savings
- $325.0 million delayed-draw borrowing refinanced 6.125% Senior Notes, maturing April 2031
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other AdaptHealth Corp. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.